EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 234 filers reported holding EXELIXIS INC in Q4 2016. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $198,000 | +37.5% | 8,323 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $144,000 | -2.0% | 8,323 | 0.0% | 0.00% | +100.0% |
Q4 2019 | $147,000 | -0.7% | 8,323 | 0.0% | 0.00% | -50.0% |
Q3 2019 | $148,000 | -93.6% | 8,323 | -92.3% | 0.00% | -92.0% |
Q2 2019 | $2,304,000 | -0.4% | 107,770 | +10.9% | 0.02% | 0.0% |
Q1 2019 | $2,313,000 | +84.3% | 97,152 | +52.3% | 0.02% | +56.2% |
Q4 2018 | $1,255,000 | -48.0% | 63,790 | -53.1% | 0.02% | -30.4% |
Q3 2018 | $2,412,000 | -21.2% | 136,145 | -4.3% | 0.02% | -23.3% |
Q2 2018 | $3,062,000 | -2.9% | 142,304 | 0.0% | 0.03% | -6.2% |
Q1 2018 | $3,152,000 | +567.8% | 142,304 | +815.7% | 0.03% | +700.0% |
Q4 2017 | $472,000 | +25.2% | 15,540 | 0.0% | 0.00% | +33.3% |
Q3 2017 | $377,000 | -1.6% | 15,540 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $383,000 | +122.7% | 15,540 | +95.8% | 0.00% | +200.0% |
Q1 2017 | $172,000 | +17100.0% | 7,938 | +20789.5% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 38 | +11.8% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 34 | -32.0% | 0.00% | – |
Q4 2015 | $1,000 | – | 50 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
AJO, LP | 7,636,882 | $134,561,000 | 0.80% |